Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Novartis Vaccines and Diagnostics S.r.l
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
Influenza (Flu) is an important health problem for many people in the world and is one of the top causes of death.A vaccine is given because it may prevent getting a disease. Fluvirin is an influenza vaccine that is registered medicine and commercially available in the pharmacies every year from the start of the flu season
Safety Objectives: To evaluate the safety of a single intramuscular (IM) injection of Fluvirin in adult and elderly subjects in compliance with the requirements of the current EU recommendations for c...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of AGRIPPAL S1 Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2009-2010, when Administered to Non-elderly Adult and Elderly Subjects
To evaluate the antibody response to each influenza vaccine antigen, as measured by Single Radial Hemolysis (SRH) at 21 days post-immunization in non-elderly adult and elderly subjects in compliance w...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, (Adjuvanted with MF59C.1) Influenza Vaccine, Formulation 2007-2008, when Administered to Elderly Subjects
To evaluate the antibody response to each influenza vaccine antigen, as measured by Single Radial Hemolysis (SRH) at 21 days post-vaccination in elderly subjects in compliance with the requirements of...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
A Phase II, Single Centre, Open-label, Randomized Study to Investigate Meningococcal Serogroup A, C, W-135 and Y Saccharide Specific B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
To assess whether the frequency of meningococcal serogroup A, C, W-135 and Y specific memory B Cells, measured 1 month after a 2, 4-month course of Novartis MenACWY vaccine, predicts the specific seru...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
Clinical Trial to evaluate the safety and antibody response of Agrippal flu vaccine for the 2012/2013 flu season Studio Clinico per valutare la sicurezza e la risposta anticorpale del vaccino antinfluenzale Agrippal per la stagione influenzale 2012/2013
To evaluate the safety of a single intramuscular (IM) injection of Agrippal in adult and elderly subjects. in compliance with the requirements of the current EU recommendations for clinical trials re...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
Safety Objective To compare the safety of a single intramuscular (IM) dose of the cell-derived influenza subunit vaccine (Optaflu®) with that of the egg-derived influenza subunit vaccine (Agrippal®) i...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
Clinical trial to evaluate safety and immune response to flu vaccines in individuals 50 years of age and older
To demonstrate the non-inferiority of the post-vaccination (Day 22) hemagglutination inhibition (HI) geometric mean titers (GMTs) of AGRIFLU over the corresponding GMTs of the comparator vaccine for a...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
To compare the immunogenicity of a single injection of Novartis MenACWY conjugate vaccine with the immunogenicity of a single injection of PS vaccine (Menomune), defined as the percentage of subjects ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
A Phase IIIB, Open Label, Multi-Center Extension Study of V72_28 to assess antibody persistence, and the safety and tolerability of a booster dose after the completion of the vaccination course in study V72_28. Estudio de extensión del V72_28 de fase IIIB, abierto, multicéntrico para evaluar la persistencia de anticuerpos y la seguridad y tolerabilidad de una dosis de refuerzo después de finalizar el programa de vacunación del estudio V72_28
To evaluate the antibody persistence 24 to 36 months after the completion of the vaccination course, in subjects who participated in the V72_28 study in Groups I to IV. Evaluar la persistencia d...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novartis Vaccines and Diagnostics S.r.l
MAJ Il y a 5 ans
Seasonal Fluvirin trial 2013/14
Immunogenicity Objective To evaluate the antibody response to each influenza vaccine antigen after vaccination with the TIVf vaccine, as measured by single radial hemolysis (SRH) or hemagglutination ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
Suivant